Latest News

"Stem Cell Therapeutics completes Trillium merger" go »

For information on Stem Cell Therapeutics click here

 
Trillium Therapeutics Inc. (TTI) is a research and development biopharmaceutical company with two main areas of focus: cytoprotection and immune regulation.